skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors

Journal Article · · J. Immunol.; (United States)
OSTI ID:7083043

Host-vs-graft activity presents a major obstacle for transplantation of T cell-depleted bone marrow in HLA-mismatched patients. In a primate model, conditioned exactly like leukemia patients, it was shown that residual host clonable T cells, as well as alloreactive cytotoxic precursors, were present in peripheral blood and spleen after completion of cytoreduction. We have now extended this study in a mouse model for allogeneic bone marrow transplantation. C/sub 3/H/HeJ mice were treated by 9 Gy total body irradiation (TBI), and 24 hr later their spleen cells were cultured in the presence of T cell growth factor and phytohemagglutinin according to the limit dilution procedure. After 7 days of culture the average frequency of clonable cells was 2.5 X 10(-3) compared with 37 X 10(-3) in the spleens of normal mice. The T cell derivation of the growing cells was ascertained by complement-mediated cytotoxicity with anti-Thy-1 as well as with anti-Lyt-2 and anti-Ly-3T4. In parallel, we found that the initial engraftment rate of bone marrow allograft in mice given 9 Gy TBI was lower than that found in recipients of syngeneic marrow. The initial engraftment rate was measured by the number of colony-forming units in the spleen and by splenic uptake of /sup 125/IUdR. A slight increase in TBI from 9 Gy to 11 Gy markedly reduced the difference in the number of spleen colony-forming units or the IUdR uptake between recipients of allogeneic and syngeneic bone marrow. This increase in TBI also coincided with eradication of detectable clonable T cells. Moreover, in mice transplanted with T cell-depleted bone marrow after 9 Gy TBI, we also demonstrate that cytotoxicity against donor-type target cells is present in the spleen 10 to 14 days posttransplantation, whereas in mice treated by 11 Gy TBI such alloreactivity could not be detected.

Research Organization:
Weizmann Inst. of Science, Rehovot (Israel)
OSTI ID:
7083043
Journal Information:
J. Immunol.; (United States), Vol. 2
Country of Publication:
United States
Language:
English

Similar Records

Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts
Journal Article · Mon May 15 00:00:00 EDT 1989 · Blood; (USA) · OSTI ID:7083043

Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation
Journal Article · Sun Jun 01 00:00:00 EDT 1986 · Proc. Natl. Acad. Sci. U.S.A.; (United States) · OSTI ID:7083043

Booster irradiation to the spleen following total body irradiation. A new immunosuppressive approach for allogeneic bone marrow transplantation
Journal Article · Sat Oct 15 00:00:00 EDT 1988 · J. Immunol.; (United States) · OSTI ID:7083043